Friday, November 13, 2026
5:05 PM – 5:30 PM ET – Registration
5:30 PM – 6:30 PM ET – CE Symposium
The Diplomat Beach Resort, Curio Collection by Hilton
3555 South Ocean Drive
Hollywood, FL 33019
Meeting room: Great Hall 5
PRESENTING FACULTY
 |
Laura P. Bush, DMSc, PA-C, DFAAPA Physician Assistant Fayette Area Dermatology Fayetteville, Georgia |
 |
Julia M. Riley, MD, MS. Associate Professor of Dermatology Northwestern University Feinberg School of Medicine Chicago, Illinois |
PROGRAM OVERVIEW
This live symposium will provide an overview of the changing landscape of Hidradenitis Suppurativa (HS) and highlight advances aimed at improving current care practices for the identification, diagnosis, and treatment of HS. This program will provide valuable insights for understanding the underlying mechanisms of HS, improving screening strategies and timely diagnosis, and implementing patient-centered treatment plans using the latest clinical evidence on current and emerging targeted therapies. Our expert faculty will guide learners with clinical pearls and interactive, case-based discussions, equipping clinicians with the tools they need to optimize care for patients with HS.
TARGET AUDIENCE
This activity is designed to meet the educational needs of dermatology PAs, dermatology NPs, and dermatologists involved in the management of patients with HS.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Identify the mechanisms underlying the pathophysiology of HS, including the rationale for targeted therapies
- Utilize evidence-based strategies for screening and diagnosing HS in a timely manner, including comorbidities associated with HS
- Integrate the latest clinical evidence of targeted therapies into patient-centered treatment plans for patients with HS
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 1.0 ANCC contact hours.
AAPA CREDIT DESIGNATION STATEMENT – LIVE
Med Learning Group has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event Staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to the live event at [email protected]
